BGM Group Ltd.

Market Cap

$69M

Healthcare·Drug Manufacturers - Specialty & Generic·🇨🇳 China·NASDAQ

Healthcare·Drug·🇨🇳·NASDAQ

Stock Price

$0.33-$3.25 (-90.84%)

Apr 23, 2026

Company Details

BGM Group Ltd manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussi...

CEO

Chen Xin

IPO Date

Jan 24, 2003

Website

www.bgm.ltd

Key Metrics TTM

Revenue

$13M

— YoY

Net Income

$328.8K

EPS (Diluted)

$0.05

Free Cash Flow

—

Revenue / Share

$1.74

Gross Margin

11.3%

Operating Margin

-5.4%

Net Margin

2.6%

FCF Margin

—

P/S

5.5x

P/E

208.4x

Earnings Reports

Q2 2024

May 15, 2024

$13MEPS $0.05

FY 2018

Sep 30, 2018

$50MEPS $0.74

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 24	$13M	$1M	-$679.1K

OpEx Breakdown

Quarter	SG&A
Q2 24	$2M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 18	$5M	$14.6K	$5M
Q2 19	$3M	$0	$3M
Q4 19	$5M	$0	$5M
Q2 20	$12M	$0	$12M
Q4 20	$12M	$0	$12M
Q2 21	$20M	$20M	$40M
Q4 21	$10M	$0	$10M
Q2 22	$12M	$0	$12M
Q4 22	$14M	$0	$14M
Q2 23	$9M	$0	$9M
Q4 23	$7M	$15M	$22M
Q2 24	$10M	$15M	$25M
Q4 24	$10M	$8M	$18M
Q2 25	$10M	$5M	$15M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 24	7M	—	—

Shares Outstanding